Acura Pharmaceuticals Inc (ACUR.O)

ACUR.O on Consolidated Issue listed on NASDAQ Capital Market

0.52USD
24 Dec 2014
Price Change (% chg)

$0.02 (+3.79%)
Prev Close
$0.50
Open
$0.50
Day's High
$0.52
Day's Low
$0.49
Volume
71,114
Avg. Vol
79,883
52-wk High
$2.12
52-wk Low
$0.41

ACUR.O

Chart for ACUR.O

About

Acura Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged in the research, development and commercialization of products focused on addressing medication abuse and misuse, utilizing its Aversion and Impede Technologies. Aversion is a mixture of inactive ingredients incorporated into pharmaceutical tablets and... (more)

Overall

Beta: 1.69
Market Cap (Mil.): $25.40
Shares Outstanding (Mil.): 48.85
Dividend: --
Yield (%): --

Financials

  ACUR.O Industry Sector
P/E (TTM): -- 151.53 38.61
EPS (TTM): -0.28 -- --
ROI: -75.50 -0.59 18.27
ROE: -98.71 -1.72 19.14
Search Stocks

FDA seeks more data on Acura's abuse-resistant pain drug

- Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.

15 Aug 2014

FDA seeks more data on Acura's abuse-resistant pain drug

Aug 15 - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment.

15 Aug 2014

Competitors

  Price Change
Shionogi & Co Ltd (4507.T) ¥3,200 +10.00
Johnson & Johnson (JNJ.N) $104.59 +0.31
Pfizer Inc. (PFE.N) $31.42 -0.03
Nektar Therapeutics (NKTR.OQ) $15.02 +0.23
Pain Therapeutics, Inc. (PTIE.OQ) $2.06 +0.03
Egalet Corp (EGLT.OQ) $5.97 +0.21

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks